首页 | 本学科首页   官方微博 | 高级检索  
     

南京某医院201株烟曲霉感染患者临床资料与唑类耐药情况回顾性分析
引用本文:陈玉萍 郑海林 张之烽 梅嬛 刘维达 刘沐桑. 南京某医院201株烟曲霉感染患者临床资料与唑类耐药情况回顾性分析[J]. 中华皮肤科杂志, 2022, 55(4): 316-320. DOI: 10.35541/cjd.20210646
作者姓名:陈玉萍 郑海林 张之烽 梅嬛 刘维达 刘沐桑
作者单位:1中国医学科学院、北京协和医学院皮肤病医院真菌科,南京210042;2南京大学医学院附属鼓楼医院检验科,南京210008
基金项目:国家自然科学基金青年基金(81501726);;江苏省自然科学基金(BK20150069);
摘    要:目的:总结南京某医院烟曲霉感染患者的临床特征,初步评估烟曲霉临床分离株的唑类耐药情况,以及唑类耐药烟曲霉出现的高危因素。方法:收集2017年3月至2021年2月南京市鼓楼医院检验科自住院患者中分离到的烟曲霉菌株,分析感染患者的临床资料,并对分离的烟曲霉进行唑类药物敏感性试验和 cyp51A基因及其启动子区的...

关 键 词:烟曲霉菌  分子流行病学  微生物敏感性试验  抗药性,真菌  DNA突变分析  基础疾病
收稿时间:2021-09-06

Retrospective analysis of 201 clinical isolates of Aspergillus fumigatus from a hospital in Nanjing: clinical characteristics of infected patients and azole resistance
Chen Yuping,Zheng Hailin,Zhang Zhifeng,Mei Huan,Liu Weida,Liu Musang. Retrospective analysis of 201 clinical isolates of Aspergillus fumigatus from a hospital in Nanjing: clinical characteristics of infected patients and azole resistance[J]. Chinese Journal of Dermatology, 2022, 55(4): 316-320. DOI: 10.35541/cjd.20210646
Authors:Chen Yuping  Zheng Hailin  Zhang Zhifeng  Mei Huan  Liu Weida  Liu Musang
Affiliation:1Department of Mycology, Chinese Academy of Medical Sciences and Peking Union Medical College, Nanjing 210042, China; 2Department of Laboratory, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing 210008, China
Abstract:【Abstract】 Objective To summarize clinical characteristics of patients with Aspergillus fumigatus infection in a hospital in Nanjing, to preliminarily assess azole resistance in clinical isolates of Aspergillus fumigatus, and to investigate risk factors for the emergence of azole-resistant Aspergillus fumigatus. Methods Clinical isolates of Aspergillus fumigatus were collected from inpatients in Department of Laboratory, Nanjing Drum Tower Hospital from March 2017 to February 2021. Clinical data on these infected patients were analyzed, azole sensitivity testing and mutation analysis of the cyp51A gene and its promoter region were performed for these Aspergillus fumigatus isolates. Results A total of 201 strains of Aspergillus fumigatus were collected, and mainly isolated from sputum specimens. Among the infected patients, there were 131 males and 70 females, and their age were 64.2 ± 15.8 years. The patients were mainly collected from department of respiratory medicine (79 cases) , department of intensive medicine (34 cases), department of rheumatology (19 cases), etc. Among these patients, common underlying diseases included interstitial pneumonia (32 cases), malignant tumors (18 cases), pneumonia (13 cases), trauma (12 cases) , systemic lupus erythematosus (8 cases), etc. Drug susceptibility testing showed that 6 (2.99%) strains of Aspergillus fumigatus were resistant to itraconazole and posaconazole, and 3 patients infected with azole-resistant Aspergillus fumigatus had used antifungal drugs before testing. Sequencing was performed on the cyp51A gene and its promoter region in the 6 strains of azole-resistant Aspergillus fumigatus, and showed TR34/L98H/S297T/F495I mutation in 5 strains and TR34/L98H mutation in 1 strain. Conclusion Compared with previously published data about azole resistance in China during 2010 -2015, the resistance of Aspergillus fumigatus to azoles in Nanjing Drum Tower Hospital did not increase from 2017 to 2021, and the mechanism of azole resistance was mostly associated with TR34/L98H/S297T/F495I mutation in the cyp51A gene and its promoter region.
Keywords:Aspergillus fumigatus   Molecular epidemiology   Microbial sensitivity tests   Drug resistance   fungal   DNA mutational analysis   Underlying diseases  
点击此处可从《中华皮肤科杂志》浏览原始摘要信息
点击此处可从《中华皮肤科杂志》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号